Amundi Asset Management US’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Amundi Asset Management US’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$187K	Hold	4,600	–	–	﹤0.01%	1468
2020 Q4	$199K	Hold	4,600	–	–	﹤0.01%	1407
2020 Q3	$254K	Hold	4,600	–	–	﹤0.01%	1356
2020 Q2	$290K	Hold	4,600	–	–	﹤0.01%	1333
2020 Q1	$235K	Hold	4,600	–	–	﹤0.01%	1304
2019 Q4	$366K	Hold	4,600	–	–	﹤0.01%	1375
2019 Q3	$223K	Buy	4,600 +1,000	+28%	+$52.1K	﹤0.01%	1436
2019 Q2	$189K	Hold	3,600	–	–	﹤0.01%	1484
2019 Q1	$191K	Hold	3,600	–	–	﹤0.01%	1444
2018 Q4	$148K	Buy	+3,600	New	+$135K	﹤0.01%	1436
2018 Q3	–	Sell	-11,100	Closed	-$502K	–	1663
2018 Q2	$502K	Sell	11,100 -200	-2%	-$9.11K	﹤0.01%	1340
2018 Q1	$546K	Sell	11,300 -52,200	-82%	-$2.91M	﹤0.01%	1267
2017 Q4	$2.5M	Buy	+63,500	New	+$2.37M	﹤0.01%	1028

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Amundi Asset Management US's GBT Position: Q1 2021 in Review

Amundi Asset Management US held its Global Blood Therapeutics, Inc. (GBT) position steady in Q1 2021 at 4,600 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

Amundi Asset Management US first reported a position in GBT in Q4 2017 and has held it in 13 quarters since. The position peaked at $2.5M in Q4 2017. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

Amundi Asset Management US held 4,600 shares of Global Blood Therapeutics, Inc. worth $187K as of Q1 2021.
Amundi Asset Management US left its Global Blood Therapeutics, Inc. share count unchanged in Q1 2021.
Global Blood Therapeutics, Inc. made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1468 holding.
Amundi Asset Management US first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and has held it in 13 quarters since.
Amundi Asset Management US's Global Blood Therapeutics, Inc. position peaked at $2.5M in Q4 2017.
214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.